<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-23343" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Idiopathic (Genetic) Generalized Epilepsy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>McWilliam</surname>
            <given-names>Matthew</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Asuncion</surname>
            <given-names>Ria Monica D.</given-names>
          </name>
          <aff>University of Santo Tomas, Medicine and Surgery</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Al Khalili</surname>
            <given-names>Yasir</given-names>
          </name>
          <aff>Virginia Commonwealth University</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Matthew McWilliam declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ria Monica Asuncion declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yasir Al Khalili declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>12</day>
          <month>2</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-23343.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A seizure can be defined as transient signs and symptoms associated with abnormal, hypersynchronous discharge of cortical neurons, and epilepsy is defined as a&#x000a0;brain disorder "characterized by an enduring predisposition to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social consequences of this condition." Idiopathic generalized epilepsy is a subtype of generalized epilepsy and consists of childhood absence epilepsy, juvenile absence epilepsy, juvenile myoclonic epilepsy, and generalized tonic-clonic seizures alone. It is estimated that over 50 million people are affected by epilepsy worldwide.</p>
        <p>The pathophysiology of epilepsy will depend on its etiology, with thalamocortical interaction being the most well-understood. The diagnosis of epilepsy is primarily clinical based on history and lack of neurologic findings in the interictal state, with electroencephalogram (EEG) as supportive evidence. Treatment strategies will vary on etiology and the side effect profile of medications and other treatment modalities.&#x000a0; This activity will review the diagnosis and management of idiopathic generalized epilepsy and highlight the importance of an interprofessional team in providing the highest standard of care for patients suffering from this disease.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Differentiate between different subtypes of idiopathic generalized seizures (eg, childhood absence epilepsy, juvenile myoclonic epilepsy, generalized tonic-clonic seizures) based on clinical presentations and electroencephalogram (EEG) findings.</p></list-item><list-item><p>Implement evidence-based treatment strategies, considering both the etiology and the side effect profile of antiepileptic medications and other interventions.</p></list-item><list-item><p>Assess treatment efficacy regularly, utilizing EEG and clinical evaluation to monitor seizure control and adjust therapy as needed.</p></list-item><list-item><p>Communicate effectively with patients and their families, explaining the diagnosis, treatment options, and potential side effects of both seizure activity and treatment-related effects.&#x000a0;</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23343&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23343">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-23343.s2" sec-type="Introduction">
        <title>Introduction</title>
        <p content-type="pubmed-excerpt">The definition of a seizure is an abnormal, hypersynchronous discharge of cortical neurons causing transient signs and symptoms. Epilepsy is brain disorder "characterized by an enduring predisposition to generate epileptic seizures and by the neurobiologic, cognitive, psychological, and social consequences of this condition. The definition of epilepsy requires the occurrence of at least one epileptic seizure."<xref ref-type="bibr" rid="article-23343.r1">[1]</xref><xref ref-type="bibr" rid="article-23343.r2">[2]</xref>&#x000a0;A diagnosis of epilepsy is considered in the following circumstances:<xref ref-type="bibr" rid="article-23343.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Two unprovoked seizures more than 24 hours apart</p>
          </list-item>
          <list-item>
            <p>One unprovoked seizure but with a high recurrence risk (such as abnormal baseline EEG)</p>
          </list-item>
          <list-item>
            <p>A diagnosis of an epilepsy syndrome</p>
          </list-item>
        </list>
        <p content-type="pubmed-excerpt">The terminology and classification of epilepsy have undergone significant change in recent years with the revised International League Against Epilepsy (ILAE) classification of epilepsies in 2017, replacing the 1989 classification.<xref ref-type="bibr" rid="article-23343.r4">[4]</xref> This update encompasses scientific advancement and establishes a viable clinical tool for the practicing clinician while remaining applicable for research and development of anti-epileptic therapies.&#x000a0;</p>
        <p><bold>Focal Seizures</bold> have origins&#x000a0; &#x0201c;within networks limited to one hemisphere. They may be discretely localized or more widely distributed. Focal seizures may originate in subcortical structures.&#x0201d;<xref ref-type="bibr" rid="article-23343.r5">[5]</xref>&#x000a0;Focal seizures can be further subclassified according to the following:<xref ref-type="bibr" rid="article-23343.r5">[5]</xref></p>
        <p>1. Motor onset or non-motor onset</p>
        <list list-type="bullet">
          <list-item>
            <p>Motor:(with subgroups of automatism, atonic, clonic, myoclonic, epileptic spasms, hyperkinetic, tonic)&#x000a0;
<list list-type="bullet"><list-item><p>automatism: coordinated, purposeful, repetitive motor activity, such as lip-smacking or swallowing&#x000a0;&#x000a0;</p></list-item><list-item><p>atonic: focal loss of tone</p></list-item><list-item><p>clonic: focal rhythmic jerking</p></list-item><list-item><p>myoclonic: irregular, brief focal jerking</p></list-item><list-item><p>epileptic spasms: focal flexion or extension of arms with flexion of the trunk&#x000a0;</p></list-item><list-item><p>hyperkinetic: activities such as pedaling or thrashing</p></list-item><list-item><p>tonic: sustained focal stiffening</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Non-motor (with subgroups autonomic, behavior arrest, cognitive, emotional, sensory)
<list list-type="bullet"><list-item><p>autonomic: a sense of heat or cold, flushing, gastrointestinal sensations, a sense of heat or cold, piloerection (goosebumps), palpitations, sexual arousal, respiratory changes, or other autonomic effects&#x000a0; &#x000a0;</p></list-item><list-item><p>behavior arrest:&#x000a0;behavioral arrest as the predominant aspect of the&#x000a0;<italic toggle="yes">entire</italic>&#x000a0;seizure</p></list-item><list-item><p>cognitive: deficits in language, thinking, or associated higher cortical functions, including feelings of d&#x000e9;j&#x000e0; vu or jamais vu, hallucinations, or illusions.</p></list-item><list-item><p>emotional: emotional changes, such as fear, anxiety, agitation, anger, paranoia, pleasure, joy, laughing (gelastic seizure), or crying (dacrystic seizure). These are often subjective.</p></list-item><list-item><p>sensory:&#x000a0;somatosensory sensations, such as olfactory, visual, auditory, hot or cold feeling, taste, or vestibular sensations</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>2. Intact or non-intact awareness (a surrogate marker for consciousness). Awareness means consciousness during the seizure, not being aware that a seizure has occurred. Impairment of awareness at any point constitutes non-intact awareness. Responsiveness is not a classification criterion by ILAE as focal impaired consciousness seizures can be associated with alertness and responsiveness to basic commands.</p>
        <p>3. Focal to bilateral tonic-clonic. This replaces the term "secondarily generalized tonic-clonic." "Bilateral" describes how the seizure propagates as opposed to "generalized" which describes generalized onset of the seizure location.<xref ref-type="bibr" rid="article-23343.r5">[5]</xref></p>
        <p><bold>Generalized onset seizures</bold>&#x000a0;have origins &#x0201c;originating at some point within, and rapidly engaging, bilaterally distributed networks."<xref ref-type="bibr" rid="article-23343.r5">[5]</xref>&#x000a0;Most generalized seizures are associated with impaired consciousness, so this is not a descriptive criterion. They are classified as motor or non-motor. As many seizures evolve into tonic-clonic, it is important to characterize the beginning of a seizure in detail. If a certain type of seizure only occurs when generalized (such as absence seizures), the "generalized" may be omitted.</p>
        <p>1. Motor (tonic-clonic, clonic, tonic, myoclonic, myoclonic-tonic-clonic, myoclonic-atonic, atonic, epileptic spasms). See above for a description of terms, and the following are identifying characteristics of specific types of generalized onset motor seizures:</p>
        <list list-type="bullet">
          <list-item>
            <p>Tonic-clonic seizure replaces the previous term "grand mal seizure" and is the most recognizable type. If initiated by myoclonic activity, it is classified as myotonic-tonic-clonic. The clonic phase usually decreases over the seizure course. They may be preceded by an "aura" or feeling of impending doom or other autonomic activity, but this does not contribute to focality of the seizure.</p>
          </list-item>
          <list-item>
            <p>Generalized clonic seizures begin and end with sustained jerking of the head, neck, face, and trunk. This type is most commonly seen in infants.</p>
          </list-item>
          <list-item>
            <p>Tonic seizures involve sustained extension, less commonly flexion, of a muscle group. It should be distinguished from dystonia and athetoid movement caused by antipsychotic medications.</p>
          </list-item>
          <list-item>
            <p>Atonic seizures often cause a patient to fall forward or onto the buttocks. In contrast, generalized tonic-clonic seizures generally cause a patient to fall backward.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Epileptic spasms cause flexion or extension of proximal muscles and the trunk. They occur most often in clusters and in infants, where they are called "infantile spasms."</p>
          </list-item>
        </list>
        <p>2. Non-motor or absence (typical, atypical, myoclonic, eyelid myoclonia). The ILAE classification systems retain the distinction between typical and atypical generalized seizures because of different EEG patterns, therapy, and prognosis.<xref ref-type="bibr" rid="article-23343.r5">[5]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Typical generalized seizures with non-motor manifestations are commonly referred to as absence seizures. They present with sudden onset of cessation of activity, blank stare, and unresponsiveness. They usually last several seconds and are usually less than 10 seconds long. If performed during the event, EEG would show generalized epileptiform discharges. Clinically, absence seizures have some similarities to focal onset seizures with impaired consciousness (previously called complex partial seizures). Both present with staring, but they differ clinically as focal onset seizures with impaired consciousness are significantly longer lasting 30 seconds to 2 minutes; in addition to staring other associated signs are as repeated words, screaming, crying, or hallucinations. Absence seizures last only a few seconds and usually are characterized only by momentary inattention.</p>
          </list-item>
          <list-item>
            <p>Atypical absence seizures are associated with increased muscle tonic behavior and less abrupt beginning and ending of the event. EEG during the event would show slow, irregular spike-and-wave activity at a rate of &#x0003c;3 per second.</p>
          </list-item>
          <list-item>
            <p>Myoclonic seizures are characterized by 3-per-second myoclonic jerks ratcheting the arm upwards and correspond to 3-per-second generalized spike-and-wave readings on EEG.</p>
          </list-item>
          <list-item>
            <p>Eyelid myoclonia are eyelid myoclonic jerks accompanied by upward eye deviation. If accompanied by EEG abnormalities with eye closure and photosensitivity, this triad is called Jeavons syndrome.<xref ref-type="bibr" rid="article-23343.r5">[5]</xref></p>
          </list-item>
        </list>
        <p><bold>Seizures of unknown onset</bold>. If seizures are unwitnessed or unable to be accurately described, they are given this designation. They can be motor, non-motor, or unclassified.&#x000a0;<xref ref-type="bibr" rid="article-23343.r6">[6]</xref>&#x000a0;Unclassified refers to seizures without enough descriptive information to classify or those that do not fit into other categories. Often, this includes tonic-clonic seizures for which the start is unwitnessed.<xref ref-type="bibr" rid="article-23343.r5">[5]</xref></p>
        <p>There can be significant overlap between the different classifications and differing bystander opinions about the clinical presentations; therefore, the above classifications are only a framework to define seizure origin and type. The recommended classification system first classifies seizures by location (local, generalized, or unknown); then by type of epilepsy disease (focal, generalized, combined, or unknown); and finally, if the seizure and epilepsy type are part of an overall epilepsy syndrome (eg, JME, CAE, JAE).<xref ref-type="bibr" rid="article-23343.r4">[4]</xref><xref ref-type="bibr" rid="article-23343.r5">[5]</xref></p>
        <p>The 2017 ILAE terminology introduces new terminology, such as developmental and epileptic encephalopathy.<xref ref-type="bibr" rid="article-23343.r4">[4]</xref>&#x000a0;Furthermore, the 2017 Classification also includes the following changes:<xref ref-type="bibr" rid="article-23343.r5">[5]</xref><xref ref-type="bibr" rid="article-23343.r7">[7]</xref></p>
        <list list-type="order">
          <list-item>
            <p>"Partial" becomes "focal."</p>
          </list-item>
          <list-item>
            <p>Awareness is used as a classifier of focal seizures.</p>
          </list-item>
          <list-item>
            <p>The terms dyscognitive, simple partial, complex partial, psychic, and secondarily generalized are eliminated.</p>
          </list-item>
          <list-item>
            <p>New focal seizure types include automatisms, behavior arrest, hyperkinetic, autonomic, cognitive, and emotional.</p>
          </list-item>
          <list-item>
            <p>Atonic, clonic, epileptic spasms, myoclonic, and tonic seizures can be of either focal or generalized onset.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Focal to bilateral tonic-clonic seizure replaces secondarily generalized seizure.</p>
          </list-item>
          <list-item>
            <p>New generalized seizure types are absence with eyelid myoclonia, myoclonic absence, myoclonic-atonic, myoclonic-tonic-clonic.</p>
          </list-item>
          <list-item>
            <p>Seizures of unknown onset may have features that can still be classified.</p>
          </list-item>
          <list-item>
            <p>Benign is replaced by the terms self-limited or pharmacoresponsive.</p>
          </list-item>
        </list>
        <p>This activity will focus on idiopathic (genetic) generalized epilepsy (IGE), one of the most well-recognized subgroups of generalized epilepsies. Idiopathic generalized epilepsy specifically refers to epilepsy syndromes such as juvenile myoclonic epilepsy (JME), juvenile absence epilepsy (JAE), childhood absence epilepsy (CAE), and generalized tonic-clonic seizures alone.<xref ref-type="bibr" rid="article-23343.r4">[4]</xref></p>
      </sec>
      <sec id="article-23343.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The new classification emphasizes etiology as instrumental for diagnosis, prognostic counseling, and management of epilepsy. This is also vital in determining the recurrence risk of single seizures and for making a diagnosis of epilepsy versus seizure from a cause other than underlying brain disorder.<xref ref-type="bibr" rid="article-23343.r8">[8]</xref>&#x000a0;These groups can be overlapping in patients with more than one contributing etiology, and etiology should always be considered in conjunction with classification.&#x000a0;</p>
        <p>Etiology is broken into six subgroups:<xref ref-type="bibr" rid="article-23343.r4">[4]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Structural</p>
          </list-item>
          <list-item>
            <p>Genetic</p>
          </list-item>
          <list-item>
            <p>Infectious</p>
          </list-item>
          <list-item>
            <p>Metabolic</p>
          </list-item>
          <list-item>
            <p>Immune</p>
          </list-item>
          <list-item>
            <p>Unknown</p>
          </list-item>
        </list>
        <p>Patients with idiopathic (genetic) generalized epilepsy, by definition, have no evidence of structural brain lesions on magnetic resonance imaging (MRI), as well as a lack of symptoms and signs interictally, eliminating most of the etiological groups.<xref ref-type="bibr" rid="article-23343.r9">[9]</xref><xref ref-type="bibr" rid="article-23343.r10">[10]</xref>&#x000a0;&#x000a0;</p>
        <p>A genetic role has been suggested due to twin studies demonstrating higher concordance rates in monozygotic twins than dizygotic&#x000a0;twins.<xref ref-type="bibr" rid="article-23343.r11">[11]</xref><xref ref-type="bibr" rid="article-23343.r12">[12]</xref>&#x000a0;Research into CAE has implicated chromosomes 20q, 8q24.3, and 1p. Research into JME has found that susceptibility polymorphisms BRD2&#x000a0;in chromosome 6p21.3 and&#x000a0;Cx-36 in chromosome 15q14 are associated with increased susceptibility to JME.<xref ref-type="bibr" rid="article-23343.r13">[13]</xref><xref ref-type="bibr" rid="article-23343.r14">[14]</xref><xref ref-type="bibr" rid="article-23343.r15">[15]</xref>&#x000a0;Despite this, most epilepsy is not linked to known genetic mutations.<xref ref-type="bibr" rid="article-23343.r4">[4]</xref>&#x000a0;</p>
        <p>Another factor linked to idiopathic generalized epilepsies is sleep quality and architecture. Studies revealed that sleep deprivation and underlying abnormal sleep architecture are strong triggers for seizures. However, effective antiepileptic treatment can improve sleep architecture in addition to reducing seizure likelihood.<xref ref-type="bibr" rid="article-23343.r16">[16]</xref><xref ref-type="bibr" rid="article-23343.r17">[17]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23343.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>It is estimated that 65 million people worldwide have epilepsy, and most of these patients do not have access to medical care.<xref ref-type="bibr" rid="article-23343.r18">[18]</xref><xref ref-type="bibr" rid="article-23343.r19">[19]</xref><xref ref-type="bibr" rid="article-23343.r20">[20]</xref>&#x000a0;Recent&#x000a0;CDC surveys indicate that the prevalence of epilepsy is underestimated, even in Western countries. A systemic review and meta-analyses of studies worldwide found that the prevalence of active epilepsy was 6.38 per 1000 persons, and the lifetime prevalence was 7.6 per 1000 persons. The prevalence of epilepsy does not differ between genders or by age group. The most common types of seizures and epilepsy are generalized seizures and epilepsy of unknown etiology.<xref ref-type="bibr" rid="article-23343.r21">[21]</xref> Estimates of the incidence of generalized epilepsies in the United States are at 7.7 per 100,000 person-years.<xref ref-type="bibr" rid="article-23343.r22">[22]</xref> JME is the most common of the idiopathic (genetic) generalized epilepsies, making up an estimated 3% to 11% of adolescent and adult cases of epilepsy.<xref ref-type="bibr" rid="article-23343.r23">[23]</xref></p>
      </sec>
      <sec id="article-23343.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The pathophysiology of epilepsy depends on the etiological factor causing the seizure activity.&#x000a0;Recently, a study identified the regulatory effects of cortical regions of basal ganglia and cerebellum among IGE patients and established possible links between the neuroimaging findings and epileptic symptoms.<xref ref-type="bibr" rid="article-23343.r24">[24]</xref></p>
        <p>Thalamocortical interaction that results in typical&#x000a0;absence seizures is the most clearly understood mechanism.&#x000a0;The primary channel involved is thought to be the transient low-threshold calcium channel (T-calcium) current. Disruption of this current can lead to depolarization and the onset of epileptic activity. Anticonvulsants suppressing T-calcium channels have been shown to prevent absence seizures. Anticonvulsants that increase the thalamocortical circuit's synchronization by increasing T-calcium current have been shown to worsen absence seizures in animal models.<xref ref-type="bibr" rid="article-23343.r25">[25]</xref><xref ref-type="bibr" rid="article-23343.r26">[26]</xref></p>
        <p>The intrinsic properties of thalamic neurons and the synaptic connections between populations of neurons in the nucleus reticularis thalami and thalamocortical relay nuclei aid in the production of different firing patterns that affect the state of the brain. Particularly, the transitions from tonic firing to highly synchronized burst firing mode in thalamic neurons can lead to seizures that rapidly generalize. Studying the role of the thalamus in generalized epilepsy syndromes, there may be new opportunities to better treat pharmaco-resistant generalized epilepsy through thalamic modulation and dietary therapy.<xref ref-type="bibr" rid="article-23343.r27">[27]</xref>&#x000a0;Small studies have also shown that children with IGE have abnormal baseline cerebral blood flow compared to children without IGE, which may be another potential therapeutic target.<xref ref-type="bibr" rid="article-23343.r28">[28]</xref></p>
      </sec>
      <sec id="article-23343.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>For most patients with IGE, clinical exam will be neurologically non-focal. In addition, most children will show basic cognition equivalent to children without seizures; however, more detailed cognitive testing often reveals decreased higher cortical functions. Children with absence seizures especially tend to exhibit language deficits.<xref ref-type="bibr" rid="article-23343.r29">[29]</xref><xref ref-type="bibr" rid="article-23343.r30">[30]</xref>&#x000a0;Studies reveal that a distinct neuropsychological profile consisting of impaired executive functions and reduced psychomotor speed with normal memory, previously described among patients with juvenile myoclonic epilepsy, is also manifested in all IGE patients.<xref ref-type="bibr" rid="article-23343.r31">[31]</xref>&#x000a0;In terms of external triggers, precipitating factors for all seizure types include fatigue, sleep deprivation, and alcohol consumption.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref></p>
        <p>
<bold>Juvenile Myoclonic Epilepsy (JME)</bold>
</p>
        <p>JME is a common epilepsy syndrome occurring between the ages of 8 to 26 years, with a peak incidence between 12 and 16 years. It is characterized by three potential seizure types: myoclonic jerks (usually soon after waking or when the individual is tired), generalized tonic-clonic seizures, and typical absence seizures. Myoclonic seizures are sudden, brief jerks affecting the arms, legs, face, or whole body. Generalized tonic-clonic seizures occur in about two-thirds of patients. Roughly one-third suffer from typical absence seizures, which are more likely to occur in the morning.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref>&#x000a0;About 30% of patients with JME show photosensitivity.<xref ref-type="bibr" rid="article-23343.r32">[32]</xref> Family history of epilepsy is related to an earlier age of onset in JME patients.<xref ref-type="bibr" rid="article-23343.r33">[33]</xref>&#x000a0;It is thought that patients with IGE have normal cognitive function; however, JME patients have demonstrated lower advanced cognitive function tests than controls. Supplemental functional neuroimaging studies and higher cortical function testing should be done for comprehensive management. The prognosis is good, with 85% to 90% of patients remaining seizure-free with one medication.<xref ref-type="bibr" rid="article-23343.r29">[29]</xref></p>
        <p>
<bold>Childhood Absence Epilepsy (CAE)</bold>
</p>
        <p>CAE occurs in early childhood, with a peak onset between 4 to 7 years, usually before age 10. Clinically, CAE patients experience staring and altered awareness. They usually have only absence seizures and fewer than 20 spells per day at the time of diagnosis. The hyperventilation test provokes seizures.<xref ref-type="bibr" rid="article-23343.r34">[34]</xref>&#x000a0;Typical absence seizures are brief (4 to 30 seconds) vacant episodes (loss of awareness and unresponsiveness) with impairment of consciousness associated with abrupt onset and cessation, as well as behavioral arrest or staring with no post-ictal symptoms. These episodes may be associated with orofacial automatisms.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref>&#x000a0;EEG will show typical 3 Hz spike-and-wave pattern ictally. Ethosuximide is used as first-line treatment and is effective over 50% of the time. However, ethosuximide is ineffective against non-absence seizures, so valproate is the preferred medication if another type is also present. Poor prognosis includes EEGs that have abnormal baseline slowing and generalized-tonic-clonic or myoclonic seizures as well as absence seizures.<xref ref-type="bibr" rid="article-23343.r35">[35]</xref></p>
        <p>If a child develops significant absence seizures before age 4 along with developmental delay and abnormal neurologic exam, the diagnosis of&#x000a0;glucose transporter 1 deficiency syndrome (GLUT1 DS) must be considered. This entity responds well to a ketogenic diet.<xref ref-type="bibr" rid="article-23343.r35">[35]</xref></p>
        <p>
<bold>Juvenile Absence Epilepsy (JAE)</bold>
</p>
        <p>The age at onset of seizures differentiates CAE from JAE.<xref ref-type="bibr" rid="article-23343.r36">[36]</xref>&#x000a0; JAE occurs between the ages of 7 to 16 years, with peak onset between 10 to 12 years. The predominant seizure type is absence seizures. These may happen many times a day but are not typically as frequent as CAE. Automatisms occur more frequently (especially perioral or hand automatisms). Generalized tonic-clonic seizures infrequently occur, and a small proportion may experience myoclonic seizures. Hyperventilation can trigger an absence seizure, but this is less likely than in CAE.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref></p>
        <p>
<bold>Generalized Tonic<bold>-</bold>Clonic Seizures</bold>
</p>
        <p>Generalized tonic-clonic seizures, formerly grand mal seizures, are described as seizures with a tonic phase followed by clonic muscle contractions. They arise within and rapidly affect the brain's bilateral cortical, subcortical, and brainstem networks.<xref ref-type="bibr" rid="article-23343.r37">[37]</xref>&#x000a0;The most common age of onset is mid-teens. They tend to occur shortly after waking (within 1 to 2 hours)&#x000a0;but can occur at any time. Precipitating factors, similarly to JME, include sleep deprivation, fatigue, and excessive alcohol consumption.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref></p>
      </sec>
      <sec id="article-23343.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis of IGE is primarily a clinical diagnosis based on history, however, many diagnostic tools also aid in the diagnosis. A brain MRI/MRA with contrast is standard for an initial seizure to rule out structural abnormality and visualize the meninges and vasculature. If there are any signs of infection&#x02014;such as elevated WBC, fevers, nuchal rigidity, or an immunocompromised state&#x02014;lumbar puncture (LP) should be performed. Preferably LPs should be done prior to antimicrobial administration, however, given the significant morbidity and mortality of meningitis, treatment should not be delayed. The cerebrospinal fluid should be evaluated for WBC, RBC, LDH, protein, and microbiology. Certain tests, such as for fungi or tuberculosis, may require additional lab requests and processing. Please see the companion StatPearls article on meningitis for further information.<xref ref-type="bibr" rid="article-23343.r38">[38]</xref></p>
        <p>EEGs are very important in establishing possible epileptogenic foci and characterizing the type of epilepsy. Up to 30% of initial seizures are misclassified, and EEGs can be very useful in differentiating seizure types. EEGs show interictal epileptiform discharges in about 10% to 50% of patients on the first EEG, and sensitivity increases with the number of EEGs performed and test duration.<xref ref-type="bibr" rid="article-23343.r9">[9]</xref><xref ref-type="bibr" rid="article-23343.r39">[39]</xref>&#x000a0;Current reviews emphasize the need for longer recordings, especially 24-hour ambulatory EEGs, that show discharges reflecting circadian and sleep-wake cycle-associated changes.<xref ref-type="bibr" rid="article-23343.r40">[40]</xref></p>
        <p>IGE is characterized by generalized spike-and-wave complexes 2 to 5 Hz, usually with frontal prominence. Hyperventilation and photic stimulation increase EEG sensitivity in generalized, but not focal, epilepsy.<xref ref-type="bibr" rid="article-23343.r39">[39]</xref></p>
        <p>In CAE and JAE, there are high amplitude ictal spike-wave discharges (2.5 to 4 Hz) lasting longer than 4 seconds. Recent reviews on CAE revealed interictal findings related to focal polyspike discharges.<xref ref-type="bibr" rid="article-23343.r41">[41]</xref>&#x000a0;JME characteristically demonstrates generalized spike-wave discharges at 3 to 6 Hz.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref><xref ref-type="bibr" rid="article-23343.r42">[42]</xref>&#x000a0;EEGs on patients with JME show photosensitivity about 30% of the time.<xref ref-type="bibr" rid="article-23343.r43">[43]</xref>&#x000a0;The presence of a polyspike train pattern is highly associated with drug-resistant IGE.<xref ref-type="bibr" rid="article-23343.r44">[44]</xref>&#x000a0;&#x000a0;</p>
      </sec>
      <sec id="article-23343.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment of IGE is centered around antiepileptic medication (AED) and patient education to promote an awareness of precipitating factors. The treatment goal is for satisfactory seizure control on minimal therapy, preferably monotherapy. Currently, there are 26 FDA-approved antiepileptics, and 9 are commonly used for IGE.<xref ref-type="bibr" rid="article-23343.r20">[20]</xref></p>
        <p>Valproate monotherapy is commonly used for IGE, with the exception of CAE where ethosuximide is preferred if exclusively absence seizures are present.<xref ref-type="bibr" rid="article-23343.r45">[45]</xref>&#x000a0;Topiramate is effective for generalized tonic-clonic seizures alone, while levetiracetam is effective for myoclonic seizures and is often used for IGE in women of childbearing age.<xref ref-type="bibr" rid="article-23343.r45">[45]</xref><xref ref-type="bibr" rid="article-23343.r46">[46]</xref></p>
        <p>Sodium valproate remains the most commonly used AED for generalized seizures, with 75% of patients remaining seizure-free on this alone. It has the additional benefit of preventing the recurrence of absence status epilepticus and is particularly useful in photosensitive patients.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref>&#x000a0;Common adverse effects are weight gain, hair loss, tremors, gastrointestinal upset, and teratogenicity. It can also be hepatoxic and interacts with many medications.<xref ref-type="bibr" rid="article-23343.r45">[45]</xref><xref ref-type="bibr" rid="article-23343.r47">[47]</xref></p>
        <p>Ethosuximide is used to treat typical absence seizures; however, it does not prevent generalized tonic-clonic seizures or myoclonic seizures, limiting its use mostly to patients with CAE. Side effects include weight loss, drowsiness, headache, and gastrointestinal upset. Behavioral changes can also occur, and side effects are usually dose-related.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref></p>
        <p>Lamotrigine is also used first-line as it can control typical absence seizures as well as generalized tonic-clonic seizures with variable efficacy associated with myoclonic seizures. There is a risk of Stevens-Johnson syndrome, and dose escalation should be gradual. Sodium valproate inhibits its metabolism, so lower doses are required when co-prescribed. Common side effects include headache, gastrointestinal upset, dizziness, ataxia, and tremors.&#x000a0;Overall, ethosuximide and valproic acid are preferable to lamotrigine as initial monotherapy in CAE.<xref ref-type="bibr" rid="article-23343.r48">[48]</xref></p>
        <p>Both carbamazepine and oxcarbazepine have been shown to worsen seizures in JME. However, carbamazepine has been used as an alternative treatment option for refractory IGE under close supervision, particularly for patients with generalized tonic-clonic seizures.<xref ref-type="bibr" rid="article-23343.r49">[49]</xref><xref ref-type="bibr" rid="article-23343.r50">[50]</xref></p>
        <p>Cenobamate was FDA-approved for focal-onset seizures in 2019 and has recently been found to reduce the frequency of attacks among patients with generalized epilepsy and combined generalized and focal epilepsy. Its proposed mechanism of action is blocking persistent sodium currents and increasing GABA-A activity.<xref ref-type="bibr" rid="article-23343.r51">[51]</xref>&#x000a0;</p>
        <p>Perampanel is a novel class of drug, an AMPA receptor antagonist, that decreases post-synaptic glutamate activity. Glutamate is the primary transmitter involved in generalization of seizures, so this AED class has significant therapeutic potential.&#x000a0; Currently, it is used for generalized tonic-clonic seizures and is generally well tolerated. Adverse effects include fatigue, dizziness, behavioral disturbances, and falls. Use in IGEs aside from generalized tonic-clonic seizures is still being studied.<xref ref-type="bibr" rid="article-23343.r52">[52]</xref></p>
        <p>Other medications used in drug-resistant IGE include levetiracetam, clonazepam, and the recently approved brivaracetam.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref><xref ref-type="bibr" rid="article-23343.r53">[53]</xref></p>
        <p>Resective surgery is not generally a potential treatment option for IGE due to a lack of a specific epileptogenic focus, so neuromodulation interventions have been used instead. The first neuromodulatory device used for epilepsy treatment is the vagus nerve stimulator procedure (VNS), which has been used for over 20 years in over 100,000 patients. It is thought to work by desynchronizing cortical activity and&#x000a0;is well-tolerated among children with medically intractable primary generalized epilepsy.<xref ref-type="bibr" rid="article-23343.r54">[54]</xref><xref ref-type="bibr" rid="article-23343.r55">[55]</xref>&#x000a0;Other neuromodulatory techniques that are currently being studied include deep brain stimulation, responsive neurostimulation, and transcranial magnetic stimulation.<xref ref-type="bibr" rid="article-23343.r56">[56]</xref>&#x000a0;</p>
        <p>A ketogenic diet (high-fat, low carbohydrate, adequate protein) has been used to treat refractory seizures since at least 1921, and fasting has been noted to improve seizure control since the time of Hippocrates. Effectiveness is linked to decreased fluctuations in blood glucose, but the exact therapeutic mechanism is not completely understood. Proposed mechanisms include:&#x000a0;mitochondrial regulation; effects of ketone bodies on neuronal function and neurotransmitter release; antiepileptic effects of fatty acids; membrane potential hyperpolarization; increased GABA synthesis; and decreased release of glutamate, norepinephrine, and adenosine. When experienced dieticians are involved, nutritional deficiencies are rare, and the primary obstacle is helping patients adhere to a strict diet. Although primarily studied in children, ketogenic diets have also been effective for intractable seizures in adults.<xref ref-type="bibr" rid="article-23343.r57">[57]</xref><xref ref-type="bibr" rid="article-23343.r58">[58]</xref></p>
      </sec>
      <sec id="article-23343.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>
<bold>Focal Epilepsy with Impaired Awareness</bold>
</p>
        <p>The primary differential diagnosis to consider when considering idiopathic (genetic) generalized epilepsy is focal epilepsy with impaired awareness, as this can have implications for treatment. Typical absences seizures are usually shorter than 10 seconds, with an abrupt start and stop, and no associated aura. They can often be provoked by hyperventilation and often are associated with automatism of the face. Focal epilepsy with impaired awareness usually causes longer seizures&#x02014;30 seconds to 2 minutes&#x02014;and are often associated with an aura.&#x000a0;</p>
        <p>
<bold>Syncope</bold>
</p>
        <p>Lack of cerebral blood flow, such as with hypotension or cardiac arrhythmia, can often cause generalized tonic-clonic seizures but is not associated with underlying epilepsy. This is especially common if a patient is secured in an upright position when a syncopal event occurs, such as with a fastened seatbelt in a car. An electrocardiogram is necessary in all cases where a patient presents with a loss of consciousness.</p>
        <p>
<bold>Non-epileptic seizures&#x000a0;</bold>
</p>
        <p>An important distinction for IGE is the differentiation of true epileptic seizures from psychogenic nonepileptic seizures (formerly called pseudoseizures). Psychogenic nonepileptic seizures (PNES) are episodic motor, sensory, mental, or autonomic manifestations resembling epileptic seizures but without corresponding neuronal activity on EEG. Patients often have a history of abuse or trauma, and this is often considered a form of conversion disorder. PNES affects 20% to 30% of patients at epilepsy centers, and patients can be on high doses of AEDs with corresponding adverse effects. In addition, between 5% to 40% of patients with PNES also have epilepsy, further compounding the diagnosis.<xref ref-type="bibr" rid="article-23343.r59">[59]</xref>&#x000a0;Please see our companion StatPearls article, "Psychogenic Nonepileptic Seizures," for further information.<xref ref-type="bibr" rid="article-23343.r60">[60]</xref></p>
        <p>
<bold>De Novo Absence Status Epilepticus of Late-onset</bold>
</p>
        <p>De novo absence status epilepticus of late onset (DNASLO) occurs in the elderly with clinical and EEG features suggestive of late-onset IGE. Sudden confusion in the elderly should be thoroughly evaluated by accurate clinical history with the aim of identifying seizures and nonconvulsive status epilepticus. In elderly patients presenting with DNASLO, a diagnosis of late-onset IGE should be considered in the differential diagnosis, and EEG is often required to fully evaluate this condition. Sudden discontinuation of benzodiazepines or new antibiotic administration are common causes of this type of epilepsy.<xref ref-type="bibr" rid="article-23343.r61">[61]</xref>&#x000a0;<bold>&#x000a0;</bold></p>
        <p>
<bold>Jeavons Syndrome</bold>
</p>
        <p>Epilepsy with eyelid myoclonia, or Jeavons syndrome, may account for up to 13% of generalized epilepsies but is frequently under-reported and under-recognized. The diagnosis of this condition is usually delayed and typically presents as IGE manifested by the triad of eyelid myoclonia with or without absence seizures, eyelid closure-elicited EEG activity, and photosensitivity. Most patients develop medically refractory epilepsy and seizures that tend to persist throughout life.<xref ref-type="bibr" rid="article-23343.r62">[62]</xref><xref ref-type="bibr" rid="article-23343.r63">[63]</xref></p>
      </sec>
      <sec id="article-23343.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for CAE is very good, with most children (80% to 90%) achieving remission by 12 years of age.&#x000a0;Recent studies showed terminal remission after 27 years of treatment; therefore the conclusion was reached that remission of IGE is primarily a function of time.<xref ref-type="bibr" rid="article-23343.r64">[64]</xref>&#x000a0;Favorable long-term seizure outcomes in adult-onset IGE patients are also seen, demonstrated by the high rates of early remission pattern as compared to patients&#x000a0;with a younger onset<xref ref-type="bibr" rid="article-23343.r65">[65]</xref>&#x000a0;</p>
        <p>Typical absence seizures are responsive to one or two AEDs in most cases. Prognosis becomes less favorable if other seizure types develop. There is debate about whether these cases represent one of the other IGEs such as JAE or JME.<xref ref-type="bibr" rid="article-23343.r10">[10]</xref>&#x000a0;More than 80% of patients achieve remission in CAE and JAE with appropriate treatment.&#x000a0;</p>
        <p>Once patients have a significant seizure-free interval, neurologists often attempt to decrease or taper off AEDs to minimize adverse effects depending on the underlying epilepsy type and other clinical factors. The appropriate time to taper AEDs after a seizure-free interval is debatable and must be done with careful monitoring.</p>
      </sec>
      <sec id="article-23343.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Seizures and epilepsy have signnificant associated morbidity. Recurrent seizures are associated with a 12-month follow-up&#x000a0;of 40% to 60% risk of bodily injury such as burns, fractures, and concussions. This shows the importance of adequate seizure control.<xref ref-type="bibr" rid="article-23343.r20">[20]</xref></p>
        <p>A dreaded complication of seizures is status epilepticus (SE) which is defined as seizure activity lasting longer than five minutes or two or more seizures occurring within 5 minutes without complete recovery between seizures.&#x000a0;It can occur in all forms of epilepsy and can be convulsive or non-convulsive. Surprisingly, convulsive status is uncommon in IGE and responds rapidly to treatment with IV benzodiazepines. Non-convulsive SE is more common in IGE and characteristically demonstrates frequent episodes of absence seizures with a&#x000a0;clear onset and offset, with associated myoclonus being common, and often terminates with a generalized tonic-clonic seizure. Non-convulsive SE also responds rapidly to treatment with IV benzodiazepines&#x000a0;or valproate.<xref ref-type="bibr" rid="article-23343.r66">[66]</xref><xref ref-type="bibr" rid="article-23343.r67">[67]</xref>&#x000a0;Convulsive SE is associated with clear mortality and is considered a medical emergency. The long-term effects of non-convulsive SE are less well-defined.</p>
        <p>Sudden unexpected death in epilepsy (SUDEP) are deaths that are not attributable to any specific medical condition, trauma, drowning, or status epilepticus. The underlying cause of this condition remains unknown, but some studies have suggested that the risk of SUDEP was lower in idiopathic epilepsy when compared to other epilepsies. Furthermore, research has determined that female patients are at lower risk for this complication.<xref ref-type="bibr" rid="article-23343.r68">[68]</xref></p>
        <p>Drug-resistant epilepsy can serve as a challenge to review the initial diagnosis and consider alternative therapeutic strategies. Initial misclassification of seizure or epilepsy type, along with the diagnosis of nonepileptic seizures, must be considered.<xref ref-type="bibr" rid="article-23343.r69">[69]</xref><xref ref-type="bibr" rid="article-23343.r70">[70]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-23343.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Epilepsy can be a lifelong disease with significant medical burdern and a need for strict medication compliance. Decreased quality of life in IGE patients is associated with poor seizure control, psychiatric comorbidity,&#x000a0; unemployment, and other adverse outcomes.<xref ref-type="bibr" rid="article-23343.r71">[71]</xref>&#x000a0;</p>
        <p>Patients and family members require education on safety precautions, along with lifestyle training such as avoiding unsupervised swimming, working at heights, or operating heavy machinery. They require counseling on sleep hygiene and medication compliance. They should be counseled against alcohol consumption and illicit drug use. Driving restrictions vary depending on the country or region, and patients and caregivers must be aware of these restrictions.<xref ref-type="bibr" rid="article-23343.r72">[72]</xref></p>
      </sec>
      <sec id="article-23343.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>IGE requires an integrated approach by an interprofessional care team to provide optimal care. Patients with absence seizures can pose a particular diagnostic challenge. A high index of suspicion is required by primary care providers in the communities, including primary care clinicians, teachers, school nurses, and social workers, to identify patients with this disorder early.&#x000a0;The hope is that the latest ILAE classification of epilepsies will help facilitate improved care delivery.&#x000a0;</p>
        <p>Once the diagnosis is made, the patient needs regular follow-up with a neurologist and primary care clinician. Patients with IGE may have significant executive dysfunction in multiple domains. This requires screening for executive dysfunctions and a possible role for cognitive retraining.<xref ref-type="bibr" rid="article-23343.r73">[73]</xref>&#x000a0;</p>
        <p>Care coordination between medical providers can help decrease complications and ensure optimal treatment. Social workers can help identify barriers to optimal clinical care and communicate these findings to the clinical team. Specialty-trained nurses should provide education on safety precautions, medication compliance, and monitoring for adverse outcomes. The clinical pharmacists augment this role by educating the patient and family on possible adverse reactions of AEDs and communicating these findings to the clinical team if they occur. Simple dose adjustments can be made to minimize adverse outcomes, increasing compliance with therapy.</p>
        <p>With ongoing treatment, the patient will need a reliable first port of call with future day-to-day questions relating to their epilepsy diagnosis and treatment. Nurses play this critical role and help establish a strong patient medical professional relationship to promote better patient care. They can also assess medication compliance and observe for any adverse reactions to medications at follow-up visits. Open communication in an interprofessional team leads to optimal therapy and outcomes.</p>
      </sec>
      <sec id="article-23343.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=23343&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=23343">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/idiopathic-genetic-generalized-epilepsy/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=23343">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/23343/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=23343">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-23343.s15">
        <title>References</title>
        <ref id="article-23343.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="editor">
              <name>
                <surname>Bromfield</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Cavazos</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sirven</surname>
                <given-names>JI</given-names>
              </name>
            </person-group>
            <source>An Introduction to Epilepsy [Internet]</source>
            <publisher-name>American Epilepsy Society</publisher-name>
            <publisher-loc>West Hartford (CT)</publisher-loc>
            <year>2006</year>
            <pub-id pub-id-type="pmid">20821849</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berg</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Berkovic</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Brodie</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Buchhalter</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>van Emde Boas</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Glauser</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Mathern</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nordli</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Plouin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
            </person-group>
            <article-title>Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009.</article-title>
            <source>Epilepsia</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>676</fpage>
            <page-range>676-85</page-range>
            <pub-id pub-id-type="pmid">20196795</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Acevedo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arzimanoglou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bogacz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Elger</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Engel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Forsgren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Glynn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hesdorffer</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>BI</given-names>
              </name>
              <name>
                <surname>Mathern</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Perucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Tomson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>ILAE official report: a practical clinical definition of epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>475</fpage>
            <page-range>475-82</page-range>
            <pub-id pub-id-type="pmid">24730690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Berkovic</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Capovilla</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Connolly</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Guilhoto</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mathern</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Nordli</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Perucca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Tomson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Zuberi</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology.</article-title>
            <source>Epilepsia</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>512</fpage>
            <page-range>512-521</page-range>
            <pub-id pub-id-type="pmid">28276062</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Haut</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Higurashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Lagae</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Peltola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roulet Perez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Schulze-Bonhage</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Somerville</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yacubian</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Zuberi</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Instruction manual for the ILAE 2017 operational classification of seizure types.</article-title>
            <source>Epilepsia</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>531</fpage>
            <page-range>531-542</page-range>
            <pub-id pub-id-type="pmid">28276064</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>The New Classification of Seizures by the International League Against Epilepsy 2017.</article-title>
            <source>Curr Neurol Neurosci Rep</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>6</issue>
            <fpage>48</fpage>
            <pub-id pub-id-type="pmid">28425015</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Cross</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Higurashi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hirsch</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jansen</surname>
                <given-names>FE</given-names>
              </name>
              <name>
                <surname>Lagae</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mosh&#x000e9;</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Peltola</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Roulet Perez</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Zuberi</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.</article-title>
            <source>Epilepsia</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>58</volume>
            <issue>4</issue>
            <fpage>522</fpage>
            <page-range>522-530</page-range>
            <pub-id pub-id-type="pmid">28276060</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Balestrini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Arzimanoglou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bl&#x000fc;mcke</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scheffer</surname>
                <given-names>IE</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zelano</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>MC</given-names>
              </name>
            </person-group>
            <article-title>The aetiologies of epilepsy.</article-title>
            <source>Epileptic Disord</source>
            <year>2021</year>
            <month>Feb</month>
            <day>01</day>
            <volume>23</volume>
            <issue>1</issue>
            <fpage>1</fpage>
            <page-range>1-16</page-range>
            <pub-id pub-id-type="pmid">33720020</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guerrini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marini</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barba</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Generalized epilepsies.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2019</year>
            <volume>161</volume>
            <fpage>3</fpage>
            <page-range>3-15</page-range>
            <pub-id pub-id-type="pmid">31307608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koutroumanidis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bourvari</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Idiopathic generalized epilepsies: clinical and electroencephalogram diagnosis and treatment.</article-title>
            <source>Expert Rev Neurother</source>
            <year>2005</year>
            <month>Nov</month>
            <volume>5</volume>
            <issue>6</issue>
            <fpage>753</fpage>
            <page-range>753-67</page-range>
            <pub-id pub-id-type="pmid">16274333</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berkovic</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Hopper</surname>
                <given-names>JL</given-names>
              </name>
            </person-group>
            <article-title>Epilepsies in twins: genetics of the major epilepsy syndromes.</article-title>
            <source>Ann Neurol</source>
            <year>1998</year>
            <month>Apr</month>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>435</fpage>
            <page-range>435-45</page-range>
            <pub-id pub-id-type="pmid">9546323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Corey</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Pellock</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Solaas</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Nance</surname>
                <given-names>WE</given-names>
              </name>
              <name>
                <surname>DeLorenzo</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>The occurrence of epilepsy and febrile seizures in Virginian and Norwegian twins.</article-title>
            <source>Neurology</source>
            <year>1991</year>
            <month>Sep</month>
            <volume>41</volume>
            <issue>9</issue>
            <fpage>1433</fpage>
            <page-range>1433-6</page-range>
            <pub-id pub-id-type="pmid">1891093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steinlein</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stoodt</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kretz</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Janz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Propping</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Possible association of a silent polymorphism in the neuronal nicotinic acetylcholine receptor subunit alpha4 with common idiopathic generalized epilepsies.</article-title>
            <source>Am J Med Genet</source>
            <year>1997</year>
            <month>Jul</month>
            <day>25</day>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>445</fpage>
            <page-range>445-9</page-range>
            <pub-id pub-id-type="pmid">9259383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado-Escueta</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Medina</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Serratosa</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Castroviejo</surname>
                <given-names>IP</given-names>
              </name>
              <name>
                <surname>Gee</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Weissbecker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Westling</surname>
                <given-names>BW</given-names>
              </name>
              <name>
                <surname>Fong</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Alonso</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Cordova</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Shah</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sainz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rubio-Donnadieu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Sparkes</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Mapping and positional cloning of common idiopathic generalized epilepsies: juvenile myoclonus epilepsy and childhood absence epilepsy.</article-title>
            <source>Adv Neurol</source>
            <year>1999</year>
            <volume>79</volume>
            <fpage>351</fpage>
            <page-range>351-74</page-range>
            <pub-id pub-id-type="pmid">10514826</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hempelmann</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Heils</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Confirmatory evidence for an association of the connexin-36 gene with juvenile myoclonic epilepsy.</article-title>
            <source>Epilepsy Res</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>71</volume>
            <issue>2-3</issue>
            <fpage>223</fpage>
            <page-range>223-8</page-range>
            <pub-id pub-id-type="pmid">16876983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lehner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Frueh</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Datta</surname>
                <given-names>AN</given-names>
              </name>
            </person-group>
            <article-title>Sleep quality and architecture in Idiopathic generalized epilepsy: A systematic review and meta-analysis.</article-title>
            <source>Sleep Med Rev</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>65</volume>
            <fpage>101689</fpage>
            <pub-id pub-id-type="pmid">36037570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tav&#x0015f;anl&#x00131;</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>K&#x00131;nay</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Effect of Sleep on Epileptic Discharges in Patients with Idiopathic Generalized Epilepsy.</article-title>
            <source>Clin EEG Neurosci</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>54</volume>
            <issue>5</issue>
            <fpage>489</fpage>
            <page-range>489-496</page-range>
            <pub-id pub-id-type="pmid">35238216</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ngugi</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bottomley</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kleinschmidt</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Newton</surname>
                <given-names>CR</given-names>
              </name>
            </person-group>
            <article-title>Estimation of the burden of active and life-time epilepsy: a meta-analytic approach.</article-title>
            <source>Epilepsia</source>
            <year>2010</year>
            <month>May</month>
            <volume>51</volume>
            <issue>5</issue>
            <fpage>883</fpage>
            <page-range>883-90</page-range>
            <pub-id pub-id-type="pmid">20067507</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meinardi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Reis</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>JW</given-names>
              </name>
              <collab>ILAE Commission on the Developing World</collab>
            </person-group>
            <article-title>The treatment gap in epilepsy: the current situation and ways forward.</article-title>
            <source>Epilepsia</source>
            <year>2001</year>
            <month>Jan</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>136</fpage>
            <page-range>136-49</page-range>
            <pub-id pub-id-type="pmid">11207798</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kanner</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Bicchi</surname>
                <given-names>MM</given-names>
              </name>
            </person-group>
            <article-title>Antiseizure Medications for Adults With Epilepsy: A Review.</article-title>
            <source>JAMA</source>
            <year>2022</year>
            <month>Apr</month>
            <day>05</day>
            <volume>327</volume>
            <issue>13</issue>
            <fpage>1269</fpage>
            <page-range>1269-1281</page-range>
            <pub-id pub-id-type="pmid">35380580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fiest</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Sauro</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Wiebe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Patten</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Dykeman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pringsheim</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Lorenzetti</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Jett&#x000e9;</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.</article-title>
            <source>Neurology</source>
            <year>2017</year>
            <month>Jan</month>
            <day>17</day>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>296</fpage>
            <page-range>296-303</page-range>
            <pub-id pub-id-type="pmid">27986877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Neligan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>JW</given-names>
              </name>
            </person-group>
            <article-title>The epidemiology of the epilepsies.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2012</year>
            <volume>107</volume>
            <fpage>113</fpage>
            <page-range>113-33</page-range>
            <pub-id pub-id-type="pmid">22938966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Senf</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schmitz</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Holtkamp</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Janz</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Prognosis of juvenile myoclonic epilepsy 45 years after onset: seizure outcome and predictors.</article-title>
            <source>Neurology</source>
            <year>2013</year>
            <month>Dec</month>
            <day>10</day>
            <volume>81</volume>
            <issue>24</issue>
            <fpage>2128</fpage>
            <page-range>2128-33</page-range>
            <pub-id pub-id-type="pmid">24212391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Pei</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Luo</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Distinct effects of the basal ganglia and cerebellum on the thalamocortical pathway in idiopathic generalized epilepsy.</article-title>
            <source>Hum Brain Mapp</source>
            <year>2021</year>
            <month>Aug</month>
            <day>01</day>
            <volume>42</volume>
            <issue>11</issue>
            <fpage>3440</fpage>
            <page-range>3440-3449</page-range>
            <pub-id pub-id-type="pmid">33830581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCormick</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus.</article-title>
            <source>J Neurosci</source>
            <year>1992</year>
            <month>Jan</month>
            <volume>12</volume>
            <issue>1</issue>
            <fpage>278</fpage>
            <page-range>278-89</page-range>
            <pub-id pub-id-type="pmid">1309574</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hosford</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Morrisett</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Huin</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice.</article-title>
            <source>Science</source>
            <year>1992</year>
            <month>Jul</month>
            <day>17</day>
            <volume>257</volume>
            <issue>5068</issue>
            <fpage>398</fpage>
            <page-range>398-401</page-range>
            <pub-id pub-id-type="pmid">1321503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindquist</surname>
                <given-names>BE</given-names>
              </name>
              <name>
                <surname>Timbie</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Voskobiynyk</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Paz</surname>
                <given-names>JT</given-names>
              </name>
            </person-group>
            <article-title>Thalamocortical circuits in generalized epilepsy: Pathophysiologic mechanisms and therapeutic targets.</article-title>
            <source>Neurobiol Dis</source>
            <year>2023</year>
            <month>Jun</month>
            <day>01</day>
            <volume>181</volume>
            <fpage>106094</fpage>
            <pub-id pub-id-type="pmid">36990364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ran</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Altered neurovascular coupling in children with idiopathic generalized epilepsy.</article-title>
            <source>CNS Neurosci Ther</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>609</fpage>
            <page-range>609-618</page-range>
            <pub-id pub-id-type="pmid">36480481</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chawla</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chaudhry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Puri</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Cognitive Dysfunction in Juvenile Myoclonic Epilepsy (JME) - A Tertiary Care Center Study.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2021</year>
            <season>Jan-Feb</season>
            <volume>24</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-50</page-range>
            <pub-id pub-id-type="pmid">33911378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jackson</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Hsu</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Stafstrom</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Almane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Koehn</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Seidenberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hermann</surname>
                <given-names>BP</given-names>
              </name>
            </person-group>
            <article-title>Language function in childhood idiopathic epilepsy syndromes.</article-title>
            <source>Brain Lang</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>193</volume>
            <fpage>4</fpage>
            <page-range>4-9</page-range>
            <pub-id pub-id-type="pmid">29610055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jeppesen</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Sandvei</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Beier</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Gesche</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Neuropsychological profile and drug treatment response in Idiopathic Generalized Epilepsy.</article-title>
            <source>Seizure</source>
            <year>2023</year>
            <month>Jul</month>
            <volume>109</volume>
            <fpage>12</fpage>
            <page-range>12-17</page-range>
            <pub-id pub-id-type="pmid">37178660</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bauer</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Gorgels</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Spetgens</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>van Klink</surname>
                <given-names>NEC</given-names>
              </name>
              <name>
                <surname>Leijten</surname>
                <given-names>FSS</given-names>
              </name>
              <name>
                <surname>Sander</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Visser</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Zijlmans</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The topographical distribution of epileptic spikes in juvenile myoclonic epilepsy with and without photosensitivity.</article-title>
            <source>Clin Neurophysiol</source>
            <year>2017</year>
            <month>Jan</month>
            <volume>128</volume>
            <issue>1</issue>
            <fpage>176</fpage>
            <page-range>176-182</page-range>
            <pub-id pub-id-type="pmid">27912171</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Najafi</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Najafi</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Safaei</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Association of Family History of Epilepsy with Earlier Age Onset of Juvenile Myoclonic Epilepsy.</article-title>
            <source>Iran J Child Neurol</source>
            <year>2016</year>
            <season>Spring</season>
            <volume>10</volume>
            <issue>2</issue>
            <fpage>10</fpage>
            <page-range>10-5</page-range>
            <pub-id pub-id-type="pmid">27247579</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bashiri</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Al Dosari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Hamad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Kentab</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Alwadei</surname>
                <given-names>AH</given-names>
              </name>
            </person-group>
            <article-title>Childhood absence epilepsy: Electro-clinical manifestations, treatment options, and outcome in a tertiary educational center.</article-title>
            <source>Int J Pediatr Adolesc Med</source>
            <year>2022</year>
            <month>Jun</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>131</fpage>
            <page-range>131-135</page-range>
            <pub-id pub-id-type="pmid">35663781</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kessler</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>McGinnis</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>A Practical Guide to Treatment of Childhood Absence Epilepsy.</article-title>
            <source>Paediatr Drugs</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>1</issue>
            <fpage>15</fpage>
            <page-range>15-24</page-range>
            <pub-id pub-id-type="pmid">30734897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Operto</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Orsini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sica</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scuoppo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Padovano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vivenzio</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>de Simone</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rinaldi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Belfiore</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mazza</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Aiello</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vetri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Donadio</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Labate</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pastorino</surname>
                <given-names>GMG</given-names>
              </name>
            </person-group>
            <article-title>Perampanel and childhood absence epilepsy: A real life experience.</article-title>
            <source>Front Neurol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>952900</fpage>
            <pub-id pub-id-type="pmid">36034267</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r37">
          <label>37</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Kodankandath</surname>
                <given-names>TV</given-names>
              </name>
              <name>
                <surname>Theodore</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Samanta</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <chapter-title>Generalized Tonic-Clonic Seizure</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>3</day>
            <pub-id pub-id-type="pmid">32119383</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r38">
          <label>38</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Hersi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Kondamudi</surname>
                <given-names>NP</given-names>
              </name>
            </person-group>
            <chapter-title>Meningitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>8</month>
            <day>12</day>
            <pub-id pub-id-type="pmid">29083833</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rosenow</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Klein</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Hamer</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Non-invasive EEG evaluation in epilepsy diagnosis.</article-title>
            <source>Expert Rev Neurother</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>425</fpage>
            <page-range>425-44</page-range>
            <pub-id pub-id-type="pmid">25779862</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seneviratne</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Brainwaves beyond diagnosis: Wider applications of electroencephalography in idiopathic generalized epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>63</volume>
            <issue>1</issue>
            <fpage>22</fpage>
            <page-range>22-41</page-range>
            <pub-id pub-id-type="pmid">34755907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dharan</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Bowden</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Seneviratne</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Dabscheck</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nurse</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Loughman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parsons</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>D'Souza</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>A cross-sectional investigation of cognition and epileptiform discharges in juvenile absence epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>64</volume>
            <issue>3</issue>
            <fpage>742</fpage>
            <page-range>742-753</page-range>
            <pub-id pub-id-type="pmid">36625418</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shahnaz</surname>
              </name>
              <name>
                <surname>Sher</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Abdul Sattar</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Clinical and EEG characteristics of Juvenile Myoclonic Epilepsy.</article-title>
            <source>Pak J Med Sci</source>
            <year>2014</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <page-range>12-5</page-range>
            <pub-id pub-id-type="pmid">24639822</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sezikli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pulat</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Tekin</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ak</surname>
                <given-names>PD</given-names>
              </name>
              <name>
                <surname>Keskink&#x00131;l&#x00131;&#x000e7;</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Atakl&#x00131;</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Frontal lobe cognitive functions and electroencephalographic features in juvenile myoclonic epilepsy.</article-title>
            <source>Epilepsy Behav</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>86</volume>
            <fpage>102</fpage>
            <page-range>102-107</page-range>
            <pub-id pub-id-type="pmid">30017834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conrad</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Chugh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ganguly</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Gugger</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Tizazu</surname>
                <given-names>EF</given-names>
              </name>
              <name>
                <surname>Shinohara</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Raghupathi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Gelfand</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Omole</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Decker</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Pathmanathan</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Ellis</surname>
                <given-names>CA</given-names>
              </name>
            </person-group>
            <article-title>Using Generalized Polyspike Train to Predict Drug-Resistant Idiopathic Generalized Epilepsy.</article-title>
            <source>J Clin Neurophysiol</source>
            <year>2022</year>
            <month>Sep</month>
            <day>01</day>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>459</fpage>
            <page-range>459-465</page-range>
            <pub-id pub-id-type="pmid">33298682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Antiseizure medications for idiopathic generalized epilepsies: a systematic review and network meta-analysis.</article-title>
            <source>J Neurol</source>
            <year>2023</year>
            <month>Oct</month>
            <volume>270</volume>
            <issue>10</issue>
            <fpage>4713</fpage>
            <page-range>4713-4728</page-range>
            <pub-id pub-id-type="pmid">37378757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ballv&#x000e9;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Salas-Puig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Llaurad&#x000f3;</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Raspall</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Abraira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Santamarina</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Toledo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Levetiracetam as first-line monotherapy for Idiopathic Generalized Epilepsy in women.</article-title>
            <source>Acta Neurol Scand</source>
            <year>2021</year>
            <month>Apr</month>
            <volume>143</volume>
            <issue>4</issue>
            <fpage>407</fpage>
            <page-range>407-412</page-range>
            <pub-id pub-id-type="pmid">33452703</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nevitt</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Sudell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Weston</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tudur Smith</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Marson</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2017</year>
            <month>Dec</month>
            <day>15</day>
            <volume>12</volume>
            <issue>12</issue>
            <fpage>CD011412</fpage>
            <pub-id pub-id-type="pmid">29243813</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brigo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Igwe</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Lattanzi</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2019</year>
            <month>Feb</month>
            <day>08</day>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>CD003032</fpage>
            <pub-id pub-id-type="pmid">30734919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kenyon</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mintzer</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nei</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Carbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsy.</article-title>
            <source>Seizure</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>23</volume>
            <issue>3</issue>
            <fpage>234</fpage>
            <page-range>234-6</page-range>
            <pub-id pub-id-type="pmid">24370318</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gelisse</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Genton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kuate</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pesenti</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baldy-Moulinier</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Crespel</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.</article-title>
            <source>Epilepsia</source>
            <year>2004</year>
            <month>Oct</month>
            <volume>45</volume>
            <issue>10</issue>
            <fpage>1282</fpage>
            <page-range>1282-6</page-range>
            <pub-id pub-id-type="pmid">15461683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Agashe</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Worrell</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Britton</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Noe</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ritaccio</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wirrell</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Nickels</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Cascino</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Burkholder</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Cenobamate in Generalized Epilepsy and Combined Generalized and Focal Epilepsy.</article-title>
            <source>Neurol Clin Pract</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>e200133</fpage>
            <pub-id pub-id-type="pmid">37064578</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Potschka</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Trinka</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Perampanel: Does it have broad-spectrum potential?</article-title>
            <source>Epilepsia</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>60 Suppl 1</volume>
            <fpage>22</fpage>
            <page-range>22-36</page-range>
            <pub-id pub-id-type="pmid">29953584</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bast</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Schulz</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Floricel</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Morita</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cleveland</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Elshoff</surname>
                <given-names>JP</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and tolerability of brivaracetam monotherapy in childhood and juvenile absence epilepsy: An innovative adaptive trial design.</article-title>
            <source>Epilepsia Open</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>588</fpage>
            <page-range>588-597</page-range>
            <pub-id pub-id-type="pmid">35844134</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Welch</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Sitwat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sogawa</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy.</article-title>
            <source>J Child Neurol</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>449</fpage>
            <page-range>449-452</page-range>
            <pub-id pub-id-type="pmid">29651891</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gonz&#x000e1;lez</surname>
                <given-names>HFJ</given-names>
              </name>
              <name>
                <surname>Yengo-Kahn</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Englot</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Vagus Nerve Stimulation for the Treatment of Epilepsy.</article-title>
            <source>Neurosurg Clin N Am</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>2</issue>
            <fpage>219</fpage>
            <page-range>219-230</page-range>
            <pub-id pub-id-type="pmid">30898273</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zillgitt</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Haykal</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Chehab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Staudt</surname>
                <given-names>MD</given-names>
              </name>
            </person-group>
            <article-title>Centromedian thalamic neuromodulation for the treatment of idiopathic generalized epilepsy.</article-title>
            <source>Front Hum Neurosci</source>
            <year>2022</year>
            <volume>16</volume>
            <fpage>907716</fpage>
            <pub-id pub-id-type="pmid">35992953</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nei</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ngo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sirven</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Sperling</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic diet in adolescents and adults with epilepsy.</article-title>
            <source>Seizure</source>
            <year>2014</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>439</fpage>
            <page-range>439-42</page-range>
            <pub-id pub-id-type="pmid">24675110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sampaio</surname>
                <given-names>LP</given-names>
              </name>
            </person-group>
            <article-title>Ketogenic diet for epilepsy treatment.</article-title>
            <source>Arq Neuropsiquiatr</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>74</volume>
            <issue>10</issue>
            <fpage>842</fpage>
            <page-range>842-848</page-range>
            <pub-id pub-id-type="pmid">27759811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lanzillotti</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Sarudiansky</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lombardi</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Korman</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>D Alessio</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Updated Review on the Diagnosis and Primary Management of Psychogenic Nonepileptic Seizure Disorders.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2021</year>
            <volume>17</volume>
            <fpage>1825</fpage>
            <page-range>1825-1838</page-range>
            <pub-id pub-id-type="pmid">34113112</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r60">
          <label>60</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Huff</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lui</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Murr</surname>
                <given-names>NI</given-names>
              </name>
            </person-group>
            <chapter-title>Psychogenic Nonepileptic Seizures</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2024</year>
            <month>2</month>
            <day>25</day>
            <pub-id pub-id-type="pmid">28722901</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brigo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Tavernelli</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Nardone</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Trinka</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>De novo late-onset absence status epilepticus or late-onset idiopathic generalized epilepsy? A case report and systematic review of the literature.</article-title>
            <source>Epileptic Disord</source>
            <year>2018</year>
            <month>Apr</month>
            <day>01</day>
            <volume>20</volume>
            <issue>2</issue>
            <fpage>123</fpage>
            <page-range>123-131</page-range>
            <pub-id pub-id-type="pmid">29620008</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r62">
          <label>62</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Youssef</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Wirrell</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Nickels</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Payne</surname>
                <given-names>ET</given-names>
              </name>
              <name>
                <surname>Britton</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cascino</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Wong-Kisiel</surname>
                <given-names>LC</given-names>
              </name>
            </person-group>
            <article-title>Jeavons Syndrome: Clinical Features and Response to Treatment.</article-title>
            <source>Pediatr Neurol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>86</volume>
            <fpage>46</fpage>
            <page-range>46-51</page-range>
            <pub-id pub-id-type="pmid">30082241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r63">
          <label>63</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zawar</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Knight</surname>
                <given-names>EP</given-names>
              </name>
            </person-group>
            <article-title>Epilepsy With Eyelid Myoclonia (Jeavons Syndrome).</article-title>
            <source>Pediatr Neurol</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>121</volume>
            <fpage>75</fpage>
            <page-range>75-80</page-range>
            <pub-id pub-id-type="pmid">34167046</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r64">
          <label>64</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wolf</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Remission of epilepsy as a function of time.</article-title>
            <source>Epilepsy Behav</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>61</volume>
            <fpage>46</fpage>
            <page-range>46-50</page-range>
            <pub-id pub-id-type="pmid">27300148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r65">
          <label>65</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cerulli Irelli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Orlando</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Salamone</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fisco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Barone</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Morano</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fanella</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fattouch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Manfredi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Giallonardo</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Di Bonaventura</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>High rates of early remission pattern in adult-onset compared with earlier-onset idiopathic generalized epilepsy: A long-term follow-up study.</article-title>
            <source>Seizure</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>94</volume>
            <fpage>52</fpage>
            <page-range>52-56</page-range>
            <pub-id pub-id-type="pmid">34864252</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r66">
          <label>66</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shorvon</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walker</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus in idiopathic generalized epilepsy.</article-title>
            <source>Epilepsia</source>
            <year>2005</year>
            <volume>46 Suppl 9</volume>
            <fpage>73</fpage>
            <page-range>73-9</page-range>
            <pub-id pub-id-type="pmid">16302878</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r67">
          <label>67</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bosak</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pawe&#x00142;czak</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>S&#x00142;owik</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus in patients with genetic (idiopathic) generalized epilepsy.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2019</year>
            <volume>15</volume>
            <fpage>1585</fpage>
            <page-range>1585-1592</page-range>
            <pub-id pub-id-type="pmid">31417260</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r68">
          <label>68</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duble</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>SV</given-names>
              </name>
            </person-group>
            <article-title>Sudden unexpected death in epilepsy.</article-title>
            <source>Indian J Med Res</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>145</volume>
            <issue>6</issue>
            <fpage>738</fpage>
            <page-range>738-745</page-range>
            <pub-id pub-id-type="pmid">29067975</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r69">
          <label>69</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jiang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Drug-resistant idiopathic generalized epilepsy: A meta-analysis of prevalence and risk factors.</article-title>
            <source>Epilepsy Behav</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>146</volume>
            <fpage>109364</fpage>
            <pub-id pub-id-type="pmid">37523796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r70">
          <label>70</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bartolini</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Lattanzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Pradella</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zaccara</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Drug-resistant epilepsy at the age extremes: Disentangling the underlying etiology.</article-title>
            <source>Epilepsy Behav</source>
            <year>2022</year>
            <month>Jul</month>
            <volume>132</volume>
            <fpage>108739</fpage>
            <pub-id pub-id-type="pmid">35636351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r71">
          <label>71</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Salas-Puig</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sopelana</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seijo-Raposo</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Abraira</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fonseca</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Santamarina</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Toledo</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>[Quality of life in adult patients with idiopathic generalised epilepsy. The EPILAK study].</article-title>
            <source>Rev Neurol</source>
            <year>2021</year>
            <month>Mar</month>
            <day>16</day>
            <volume>72</volume>
            <issue>6</issue>
            <fpage>195</fpage>
            <page-range>195-202</page-range>
            <pub-id pub-id-type="pmid">33710609</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r72">
          <label>72</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Asadi-Pooya</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Farazdaghi</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Driving rate in patients with seizures: Epilepsy vs. functional seizures.</article-title>
            <source>Epilepsy Behav</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>119</volume>
            <fpage>107985</fpage>
            <pub-id pub-id-type="pmid">33940523</pub-id>
          </element-citation>
        </ref>
        <ref id="article-23343.r73">
          <label>73</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Koganti</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Paneyala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sundaramurthy</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Sc</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kashyap</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Colaco</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The Impact of Idiopathic Generalized Epilepsy on Executive Functions.</article-title>
            <source>Ann Neurosci</source>
            <year>2020</year>
            <month>Jul</month>
            <volume>27</volume>
            <issue>3-4</issue>
            <fpage>131</fpage>
            <page-range>131-135</page-range>
            <pub-id pub-id-type="pmid">34556951</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
